Showing 121 - 140 results of 172 for search '"cystic fibrosis"', query time: 0.05s Refine Results
  1. 121
  2. 122

    Heme alters biofilm formation in Mycobacterium abscessus by Hadia Aftab, Jessica Samudio, Grace Wang, Lily Le, Rajesh K. Soni, Rebecca K. Donegan

    Published 2025-02-01
    “…ABSTRACT Mycobacterium abscessus (Mabs) is commonly found in the cystic fibrosis (CF) lung. During infection, Mabs can form biofilms in the lung which reduce both the ability of the immune response to clear infection and the effectiveness of antibiotic therapy. …”
    Get full text
    Article
  3. 123

    Prevalence and features of allergic bronchopulmonary aspergillosis, United States, 2016-2022. by Kaitlin Benedict, Jeremy A W Gold, Mitsuru Toda, Joy Hsu

    Published 2025-01-01
    “…To estimate national ABPA prevalence among patients with asthma or cystic fibrosis, characterize ABPA testing practices, and describe ABPA clinical features, treatment, and 6-month outcomes. …”
    Get full text
    Article
  4. 124

    Immunopathology of Airway Surface Liquid Dehydration Disease by Brandon W. Lewis, Sonika Patial, Yogesh Saini

    Published 2019-01-01
    “…Defective MCC is often associated with airway mucoobstruction, increased occurrence of respiratory infections, and progressive decrease in lung function in mucoobstructive lung diseases including cystic fibrosis (CF). In this disease, a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene results in dehydration of the airway surface liquid (ASL) layer. …”
    Get full text
    Article
  5. 125

    Heterogeneity of Clostridioides difficile asymptomatic colonization prevalence: a systematic review and meta-analysis by Daniel De-la-Rosa-Martínez, Rodrigo Villaseñor-Echavarri, Diana Vilar-Compte, Virna Mosqueda-Larrauri, Paola Zinser-Peniche, Seth Blumberg

    Published 2025-01-01
    “…Our meta-regression analysis revealed lower rates in healthy individuals and higher rates in cystic fibrosis patients and studies from North America. …”
    Get full text
    Article
  6. 126

    Chronic Disease Management in Children Based on the Five Domains of Health by Wing Lung Alvin So

    Published 2013-01-01
    “…Through a case study of a child with cystic fibrosis, the interactions among various domains of health have been discussed—namely, biomedical, physical, psychological/behavioural, and social. …”
    Get full text
    Article
  7. 127

    Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro by Toshikazu Shimane, Kazuhito Asano, Mayumi Suzuki, Tadashi Hisamitsu, Harumi Suzaki

    Published 2001-01-01
    “…Background: Long-term administration of macrolide antibiotics is recognized to be able to favorably modify the clinical condition of inflammatory diseases, such as diffuse panbronchiolitis and cystic fibrosis. However, the precise mechanisms by which macrolide antibiotics could improve clinical conditions of the patients are not well understood.…”
    Get full text
    Article
  8. 128

    Newborn Screening Saves Lives but Cannot Replace the Need for Clinical Vigilance by F. Neemuchwala, M. Taki, E. Secord, S. Z. Nasr

    Published 2018-01-01
    “…Newborn screening for cystic fibrosis (CF) enables early diagnosis and treatment leading to improved health outcomes for patients with CF. …”
    Get full text
    Article
  9. 129

    Glutamine Supplementation in Sick Children: Is It Beneficial? by Elise Mok, Régis Hankard

    Published 2011-01-01
    “…This includes premature infants, infants with gastrointestinal disease, children with Crohn's disease, short bowel syndrome, malnutrition/diarrhea, cancer, severe burns/trauma, Duchenne muscular dystrophy, sickle cell anemia, cystic fibrosis, and type 1 diabetes. Moreover, methodological issues have been noted in some studies. …”
    Get full text
    Article
  10. 130

    Autophagy in Inflammatory Diseases by Alexander J. S. Choi, Stefan W. Ryter

    Published 2011-01-01
    “…Furthermore, autophagy-dependent mechanisms have been proposed in the pathogenesis of several pulmonary diseases that involve inflammation, including cystic fibrosis and pulmonary hypertension. Strategies aimed at modulating autophagy may lead to therapeutic interventions for diseases associated with inflammation.…”
    Get full text
    Article
  11. 131

    CLINICAL PATTERNS OF MALABSORPTION SYNDROMES IN CHILDREN by Ginel Baciu, Carmen Baciu, Cristina Maria Mihai, Tatiana Chisnoiu, Ramona Mihaela Stoicescu, Adriana Luminita Balasa, Adriana Mocanu, Lorenza Forna, Alexandru Paul Baciu

    Published 2024-12-01
    “…Celiac disease (51%), cystic fibrosis (32%), and Cow’s milk protein allergy (17%) were the leading causes. …”
    Get full text
    Article
  12. 132

    Meconium Peritonitis and Periorchitis: Report of a Prenatal Case by Cem Yaşar Sanhal, İnanç Mendilcioğlu, Adnan Aslan, Murat Özekinci, Mehmet Şimşek

    Published 2014-12-01
    “…Meconium peritonitis may also be caused by viral infections (cytomegalovirus or parvovirus B19) and cystic fibrosis. Here, we report of a patient with fetal meconium peritonitis - periorchitis and perinatal management. …”
    Get full text
    Article
  13. 133

    Recent Developments in Sweat Analysis and Its Applications by Saima Jadoon, Sabiha Karim, Muhammad Rouf Akram, Abida Kalsoom Khan, Muhammad Abid Zia, Abdul Rauf Siddiqi, Ghulam Murtaza

    Published 2015-01-01
    “…Moreover, sweat comprises various biomarkers of different diseases including cystic fibrosis and diabetes. Additionally, the normalization of sampled volume of sweat is also necessary for getting efficient and useful results.…”
    Get full text
    Article
  14. 134

    Colistin: The phoenix Arises by JM Conly, BL Johnston

    Published 2006-01-01
    “…As a result, the use of polymyxin preparations has been mainly restricted to the treatment of lung infections due to multidrug-resistant (MDR) gram-negative bacteria in patients with cystic fibrosis (6,7). The emergence of bacteria resistant to most classes of commercially available antibiotics and the shortage of novel antimicrobial agents with activity against gram-negative microorganisms have led to the reemergence of polymyxins as a valuable addition to the therapeutic armamentarium. …”
    Get full text
    Article
  15. 135

    Study of Query Expansion Techniques and Their Application in the Biomedical Information Retrieval by A. R. Rivas, E. L. Iglesias, L. Borrajo

    Published 2014-01-01
    “…A corpus belonging to MEDLINE, called Cystic Fibrosis, is used as a knowledge source. Experimental results show that the proposed combinations of techniques greatly enhance the efficiency obtained by traditional queries.…”
    Get full text
    Article
  16. 136

    Inhalation Techniques Used in Patients with Respiratory Failure Treated with Noninvasive Mechanical Ventilation by Patrycja Rzepka-Wrona, Szymon Skoczynski, Dawid Wrona, Adam Barczyk

    Published 2018-01-01
    “…The administration of aerosolized medication is a basic therapy for patients with numerous respiratory tract diseases, including obstructive airway diseases (OADs), cystic fibrosis (CF), and infectious airway diseases. …”
    Get full text
    Article
  17. 137

    Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants by Sílvia A. Sousa, Christian G. Ramos, Jorge H. Leitão

    Published 2011-01-01
    “…Bcc bacteria are endowed with an extraordinary metabolic diversity and emerged in the 1980s as life-threatening and difficult-to-treat pathogens among patients suffering from cystic fibrosis. More recently, these bacteria became recognized as a threat to hospitalized patients suffering from other diseases, in particular oncological patients. …”
    Get full text
    Article
  18. 138

    A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease by Elpis Hatziagorou, Eleana Kouroukli, Vasiliki Georgopoulou, John Tsanakas

    Published 2018-01-01
    “…Novel targeted treatments for Cystic Fibrosis give rise to new hope for an ever-growing number of CF patients with various mutations. …”
    Get full text
    Article
  19. 139

    Clinical benefits and risks of remote patient monitoring: an overview and assessment of methodological rigour of systematic reviews for selected patient groups by Constanze Wartenberg, Helen Elden, Malte Frerichs, Lennart L Jivegård, Kajsa Magnusson, Georgios Mourtzinis, Ola Nyström, Kajsa Quitz, Helen Sjöland, Therese Svanberg, Helena Vallo Hult

    Published 2025-01-01
    “…For four patient groups (children with complex needs, children with cystic fibrosis, specialist maternity care, and sleep apnea), systematic reviews of adequate quality concluded that scientific evidence on clinical patient benefits of remote monitoring is very limited. …”
    Get full text
    Article
  20. 140